StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$13.65+0.75 (+5.81%)

Close on Nov 19, 2026Market cap $2.06BP/E –Yield –

Biohaven revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Biohaven

Biohaven has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Biohaven figures

See a number that looks wrong?